Published in Obesity and Diabetes Week, June 5th, 2006
The CHMP, comprised of regulators from all European Union countries, gave its positive opinion following a timely 1-year review of the Acomplia application. The recommendation to grant marketing authorization was...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.